“Just because people are getting vaccinated does not mean they do not need to social distance. Until there is sufficient data, people should follow public guidelines.”
Chiraz Guessaier, Manager of CDA Oasis, talks to pharmacology expert Dr. Mark Donaldson, Associate Principal at Vizient, about the implications and the complications of deploying the much-awaited COVID-19 vaccines. Dr. Donaldson outlines the mechanism of action of each candidate, and compares the logistical challenges of the two front runners from Moderna and Pfizer/BioNTech. He also considers the durability of the potential vaccines, and cautions against the early lifting of restrictions.
We hope you find the conversation useful. We welcome your thoughts, questions and/or suggestions about this post and other topics. Leave a comment in the box below or send us your feedback by email.
Until next time!
Chiraz Guessaier, CDA Oasis Manager
Resources